Research and Markets has announced the addition of the "Candidiasis Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Candidiasis Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Candidiasis market. It covers emerging therapies for Candidiasis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Candidiasis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Candidiasis pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Candidiasis pipeline products by the company.

Short-term Launch Highlights:

Find out which Candidiasis pipeline products will be launched in the US and Ex-US till 2020.

Summary:

  • Candidiasis phase 3 clinical trial pipeline products
  • Candidiasis phase 2 clinical trial pipeline products
  • Candidiasis phase 1 clinical trial pipeline products
  • Candidiasis preclinical research pipeline products
  • Candidiasis discovery stage pipeline products
  • Candidiasis pipeline products short-term launch highlights

Key Topics Covered:

1. Candidiasis Pipeline by Stages

2. Candidiasis Pipeline by Drug Class

3. Candidiasis Pipeline by Company

4. Candidiasis Phase 3 Clinical Trial Insights

5. Candidiasis Phase 2 Clinical Trial Insights

6. Candidiasis Phase 1 Clinical Trial Insights

7. Candidiasis Preclinical Research Insights

8. Candidiasis Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/sqk6w9/candidiasis